Authors:
LACOURCIERE Y
POOL JL
SVETKEY L
GRADMAN AH
LAROCHELLE P
DECHAMPLAIN J
SMITH WB
Citation: Y. Lacourciere et al., A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER TRIAL OF 4 DOSES OF TASOSARTAN IN PATIENTS WITH ESSENTIAL-HYPERTENSION, American journal of hypertension, 11(4), 1998, pp. 454-461
Authors:
DECHAMPLAIN J
KARAS M
NGUYEN P
CARTIER P
WISTAFF R
TOAL CB
NADEAU R
LAROCHELLE P
Citation: J. Dechamplain et al., DIFFERENT EFFECTS OF NIFEDIPINE AND AMLODIPINE ON CIRCULATING CATECHOLAMINE LEVELS IN ESSENTIAL HYPERTENSIVE PATIENTS, Journal of hypertension, 16(9), 1998, pp. 1357-1369
Authors:
DECHAMPLAIN J
KARAS M
NGUYEN P
CARTIER P
WISTAFF R
TOAL C
NADEAU R
LAROCHELLE P
Citation: J. Dechamplain et al., DIFFERENTIAL-EFFECTS OF NIFEDIPINE AND AMLODIPINE ON CIRCULATING CATECHOLAMINE LEVELS IN ESSENTIAL HYPERTENSIVE PATIENTS, Journal of hypertension, 16, 1998, pp. 2305-2305
Authors:
KARAS M
LAROCHELLE P
NADEAU R
TOAL C
DECHAMPLAIN J
Citation: M. Karas et al., INITIAL BASAL SYMPATHETIC TONE IS ASSOCIATED WITH THE FALL IN BLOOD-PRESSURE FOLLOWING THERAPY WITH NIFEDIPINE AND AMLODIPINE, Journal of hypertension, 16, 1998, pp. 31023-31023
Authors:
LEENEN FHH
WILSON TW
BOLLI P
LAROCHELLE P
MYERS M
HANDA SP
BOILEAU G
TANNER J
Citation: Fhh. Leenen et al., PATTERNS OF COMPLIANCE WITH ONCE VERSUS TWICE-DAILY ANTIHYPERTENSIVE DRUG-THERAPY IN PRIMARY-CARE - A RANDOMIZED CLINICAL-TRIAL USING ELECTRONIC MONITORING, Canadian journal of cardiology, 13(10), 1997, pp. 914-920
Authors:
LEENEN FHH
WILSON T
BOLLI P
LAROCHELLE P
MYERS M
HANDA P
BOILEAU G
TANNER J
Citation: Fhh. Leenen et al., DURATION OF ACTION AND BP CONTROL IN PATIENTS WITH PARTIAL COMPLIANCE- AMLODIPINE VS DILTIAZEM, Hypertension, 29(3), 1997, pp. 213-213
Authors:
LAROCHELLE P
FLACK JM
MARBURY TC
SARELI P
KRIEGER EM
REEVES RA
Citation: P. Larochelle et al., EFFECTS AND TOLERABILITY AT IRBESARTAN VERSUS ENALAPRIL IN PATIENTS WITH SEVERE HYPERTENSION, The American journal of cardiology, 80(12), 1997, pp. 1613
Citation: P. Larochelle, EFFECT OF QUINAPRIL ON THE ALBUMIN EXCRETION RATE IN PATIENTS WITH MILD-TO-MODERATE ESSENTIAL-HYPERTENSION, American journal of hypertension, 9(6), 1996, pp. 551-559
Authors:
MILOT A
LAMBERT R
LEBEL M
CUSSON JR
LAROCHELLE P
Citation: A. Milot et al., PROSTAGLANDINS AND RENAL-FUNCTION IN HYPERTENSIVE PATIENTS WITH UNILATERAL RENAL-ARTERY STENOSIS AND PATIENTS WITH ESSENTIAL-HYPERTENSION, Journal of hypertension, 14(6), 1996, pp. 765-771
Citation: P. Larochelle et Jm. Mccarthy, PLANAR MOTION SYNTHESIS USING AN APPROXIMATE BI-INVARIANT METRIC, Journal of mechnical design, 117(4), 1995, pp. 646-651
Citation: El. Schiffrin et al., PROGRESSIVE IMPROVEMENT IN THE STRUCTURE OF RESISTANCE ARTERIES OF HYPERTENSIVE PATIENTS AFTER 2 YEARS OF TREATMENT WITH AN ANGIOTENSIN-I-CONVERTING ENZYME-INHIBITOR - COMPARISON WITH EFFECTS OF A BETA-BLOCKER, American journal of hypertension, 8(3), 1995, pp. 229-236
Authors:
KONRAD JM
BERGERON G
ROY M
LAROCHELLE P
LEROUEIL S
Citation: Jm. Konrad et al., FIELD OBSERVATIONS OF FROST ACTION IN INTACT AND WEATHERED CHAMPLAIN SEA CLAY, Canadian geotechnical journal, 32(4), 1995, pp. 689-700
Citation: P. Larochelle et M. Baron, ENALAPRIL IN OLDER PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION, Cardiology in the elderly, 2(4), 1994, pp. 305-310
Citation: El. Schiffrin et al., PROGRESSIVE IMPROVEMENT IN THE STRUCTURE OF RESISTANCE ARTERIES OF HYPERTENSIVE PATIENTS DURING 2 YEARS OF TREATMENT WITH AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, Hypertension, 24(3), 1994, pp. 400-400
Citation: El. Schiffrin et al., EFFECTS OF A BETA-BLOCKER OR A CONVERTING-ENZYME-INHIBITOR ON RESISTANCE ARTERIES IN ESSENTIAL-HYPERTENSION, Hypertension, 23(1), 1994, pp. 83-91
Citation: El. Schiffrin et al., EFFECTS OF ANTIHYPERTENSIVE TREATMENT ON VASCULAR REMODELING IN ESSENTIAL HYPERTENSIVE PATIENTS, Journal of cardiovascular pharmacology, 24, 1994, pp. 190000051-190000056
Authors:
DANIELSON B
QUERIN S
LAROCHELLE P
SULTAN E
MOUREN M
BRYCE T
STEPNIEWSKI JP
LENFANT B
Citation: B. Danielson et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF TRANDOLAPRIL AFTER REPEATED ADMINISTRATION OF 2-MG TO PATIENTS WITH CHRONIC-RENAL-FAILURE AND HEALTHY CONTROL SUBJECTS, Journal of cardiovascular pharmacology, 23, 1994, pp. 190000050-190000059
Citation: P. Larochelle et al., A POSTMARKETING SURVEILLANCE EVALUATION OF QUINAPRIL IN 3742 CANADIANHYPERTENSIVE PATIENTS - THE ACCEPT STUDY, Clinical therapeutics, 16(5), 1994, pp. 838-853
Citation: P. Larochelle et al., A POSTMARKETING SURVEILLANCE EVALUATION OF QUINAPRIL IN 3742 CANADIANHYPERTENSIVE PATIENTS - THE ACCEPT STUDY, Clinical therapeutics, 16(5), 1994, pp. 838-853
Citation: El. Schiffrin et al., PROSPECTIVE TRIAL OF EFFECTS OF AN ANGIOT ENSIN I-CONVERTING ENZYME-INHIBITOR OR A BETA-BLOCKER ON STRUCTURE AND FUNCTION OF RESISTANCE ARTERIES IN MILD ESSENTIAL-HYPERTENSION, Archives des maladies du coeur et des vaisseaux, 87(8), 1994, pp. 979-981
Authors:
CARRUTHERS SG
LAROCHELLE P
HAYNES RB
PETRASOVITS A
SCHIFFRIN EL
Citation: Sg. Carruthers et al., REPORT OF THE CANADIAN HYPERTENSION SOCIETY CONSENSUS CONFERENCE .1. INTRODUCTION, CMAJ. Canadian Medical Association journal, 149(3), 1993, pp. 289-292